Effect of Yoghurts Enriched With XXS (Mixture of Natural Polyphenolic Compounds and Plant Extracts) on the Evolution of Weight in Overweight Subjects
NCT ID: NCT02810041
Last Updated: 2019-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
93 participants
INTERVENTIONAL
2014-11-17
2015-05-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of a Drinkable Yogurt Enriched in Proteins and Fibers on Satiety
NCT01304004
Low Fat Plant-Based Supplemented Diet Effects on Risk Factors for Chronic Non-communicable Diseases
NCT02905448
Cardio Protective Properties of a Yogurt Enriched With Bioactive Lipids of Olive Oil Products
NCT02259205
Dairy Intervention in People With Obesity
NCT04154475
Intervention With n3 LC-PUFA-supplemented Yogurt
NCT01244048
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
yoghurts enriched with XXS
yoghurts enriched with XXS
yoghurts non enriched with XXS
yoghurts non enriched with XXS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
yoghurts enriched with XXS
yoghurts non enriched with XXS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* who have provided written consent;
* and are covered by national health insurance;
* with a stable weight for 6 months and no intention to begin a diet in the coming three months;
* with a Body Mass Index (BMI) between 25 and 29.9 kg/m2 and a waist circumference \> 80 cm in women and \> 94cm in men (thresholds of the International Diabetes Federation, IDF);
* who consume dairy products such as yoghurts;
* and do not have more than two of the following risk factors of metabolic syndrome: known history of hypertension (\>130/85mmHg), hypocholesterolemia High Density Lipoprotein HDL (\< 0.4 g/L men and 0.5 g/L women), hypertriglyceridemia (\>1.5 g/L), diabetes (\> 1.1 g/L);
* presenting C Reactive Protein (CRP) \< 6mg/L.
Exclusion Criteria
* persons following a prescribed of self-prescribed diet;
* whose behaviour may interfere with the consumption of the active dairy product (more than 4h of physical activity a week, smoking more than 10 cigarettes a day, more than 2 glasses of alcohol a day, Consuming more than one bar of dark chocolate a day, 10 cups of coffee/day, 5 large cups of tea/day, supplementation with vitamins (A, C, E…), oligoelements or minerals (Se, Zn, Ca…), enriched dairy products or any supplements containing Dietary Foods for Specialized Medical Purposes (ADFMS) .
50 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Champmaillot Geriatric Department
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VAN WYMELBEKE SENOBLE 2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.